Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Updated: Jun 24, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

轻度宫硬化症:细胞学监测的安全性

M H Jones¹, D Jenkins, J Cuzick

¹Colposcopy Department, Royal Northern Hospital, London, UK.

Lancet (London, England)

|June 13, 1992

概括

此摘要是机器生成的。

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Revealing Three-Dimensional Structure of an Individual Colloidal Crystal Grain by Coherent X-Ray Diffractive Imaging.

Physical review letters·2016

Same author

[Polypharmacy after Discharge from Hospital: An Analysis Using Data of the Statutory Health Insurance (AOK) of Saxony-Anhalt].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2016

Same author

Improving the forecast for biodiversity under climate change.

Science (New York, N.Y.)·2016

Same author

Photoinduced Enhancement of the Charge Density Wave Amplitude.

Physical review letters·2016

Same author

A scientist's guide for submitting data to ZFIN.

Methods in cell biology·2016

Same author

[The role of reflectance confocal microscopy and optical coherence tomography in the diagnosis of epithelial-cystic conjunctival nevus].

Annales de dermatologie et de venereologie·2016

在宫部查上管理轻度硬化症是有争议的. 单靠细胞监测就有缺失宫内皮质新生病 (CIN) 3病变的风险,但添加第三次涂抹可以显著降低这种风险.

科学领域:

妇科妇科妇科妇科
在瘤学瘤学.
病理学病理学病理学

背景情况:

在宫部查中治疗轻度硬化症仍然存在争议.
结肠镜检查是有效的,但对许多女性来说,结果正常,但在情感上是很累的.
细胞学监测可能会忽略显著的宫病变.

研究的目的:

评估宫内皮质瘤 (CIN) 和人类乳头瘤病毒感染 (HPVI) 在细胞监测中遗漏的比例.
为了确定镜检查后是否存在异常.
评估对轻度硬化症的管理策略.

主要方法:

结肠镜检查和活检用于研究两组先前患有轻度硬化症的患者.
第1组:针对持续异常,进行细胞学监测,采用胆管镜检查.
第二组:早期的肠镜检查和治疗.

主要成果:

在细胞监测组中,平均27个月后,12%的人有CIN3.
添加第三次涂抹将CIN3风险降低到4%.
在早期的结肠镜组中,37%的人有持续的异常,但没有人有CIN3.

结论:

更多相关视频

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

相关实验视频

Last Updated: Jun 24, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

对轻度硬化症的细胞学监测有缺失CIN3病变的风险.
涉及第三次重复涂抹的策略可以显著降低这种风险.
这种方法平衡了严重癌前变化的检测和减少对结肠镜检查的需求.